Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

Martin H. Prins, Anthonie WA Lensing, Rupert Bauersachs, +9

Thrombosis Journal

Development of an in vitro model to study clot lysis activity of thrombolytic drugs

Sweta Prasad, Rajpal S. Kashyap, Jayant Y Deopujari, +3

Thrombosis Journal

Hereditary thrombophilia.

Salwa Khan, Joseph D. Dickerman

Thrombosis Journal

ThrombosisVenous DiseaseVenous ThrombosisVenous Disease TreatmentMedicine +10

Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications

Massimo Franchini, Franco Capra, Giovanni Targher, +2

Thrombosis Journal

Contact pathway of coagulation and inflammation

Yi Wu

Thrombosis Journal

ImmunologyCytoskeletonContact SystemCellular PhysiologyInflammation +20

Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring

Wolfgang Mueck, Stephan Schwers, Jan Stampfuss

Thrombosis Journal

Thrombosis in vasculitis: from pathogenesis to treatment

Giacomo Emmi, Elena Silvestri, Danilo Squatrito, +10

Thrombosis Journal

Heparin-induced thrombocytopenia: an update

Massimo Franchini

Thrombosis Journal

Hypothermia: effects on platelet function and hemostasis

Sven Van Poucke, Kris Stevens, Abraham Marcus, +1

Thrombosis Journal

Mild Therapeutic HypothermiaPlatelet FunctionThrombosisHematologySepsis +15

Thrombosis in inflammatory bowel diseases: what’s the link?

M. Giannotta, Gherardo Tapete, Giacomo Emmi, +2

Thrombosis Journal